Business
Update regarding AIM admission of RenalytixAI
Update regarding AIM admission of RenalytixAI.
About this update from Ekf Diagnostics Holdings Plc
[{"type":"text","content":"\n \nRNS Number : 1097G EKF Diagnostics Holdings PLC 01 November 2018 \n\nEKF Diagnostics Holdings plc (\"EKF\" or the \"Company\")\n \nUpdate regarding AIM admission of RenalytixAI and planned change of EKF's nominated adviser\n \nEKF Diagnostics Holdings plc (AIM: EKF) announces that, further to the announcement on 31 October confirming that Renalytix AI plc (\"RenalytixAI\") had successfully raised £22.25 million in gross proceeds, RenalytixAI will now be admitted to trading on AIM on 6 November 2018. An updated Schedule One announcement is expected to be issued on 2 November 2018.\n \nParticipants in the fundraising will be contacted by N+1 Singer, the Company or Link Asset Services to confirm updated settlement instructions.\n \nEKF and N+1 Singer, the Company's current nominated adviser and broker, have agreed that in order to preserve the independence of its nominated adviser, EKF will appoint a new nominated adviser after the admission of RenalytixAI. A further announcement will be made in this regard in due course. \n \nN+1 Singer will continue to act as broker to EKF.\n \n\n\n\nEnquiries:\n \nEKF Diagnostics Holdings plc \n\n\n \n\n\n\n\nChristopher Mills, Non-Executive Chairman\n\n\nTel: 029 2071 0570\n\n\n\n\nJulian Baines, CEO\nRichard Evans, FD & COO\n \n\n\n \n\n\n\n\nN+1 Singer (Nominated Adviser & Broker)\n\n\nTel: 020 7496 3000\n\n\n\n\nAubrey Powell / Lauren Kettle / George Tzimas (Corporate Finance)\nTom Salvesen (Corporate Broking)\n \n\n\n \n\n\n\n\nWalbrook PR Limited\n\n\nTel: 020 7933 8780 or [email protected]\n\n\n\n\nPaul McManus / Lianne Cawthorne\n\n\nMob: 07980 541 893 / 07584 391 303\n\n\n\n\n \n\n\n \n\n\n \n\n\n \n\n\n\n \n \n \nAbout EKF Diagnostics Holdings plc www.ekfdiagnostics.com\n \nEKF is a leading ...